RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2016; 27(20): 2846-2850
DOI: 10.1055/s-0036-1588601
DOI: 10.1055/s-0036-1588601
letter
Base-Free Synthesis of CF3-Containing β-Tryptamine Derivatives from N-Nosyl-2-CF3-Aziridine and Indoles
Weitere Informationen
Publikationsverlauf
Received: 26. Juli 2016
Accepted after revision: 01. September 2016
Publikationsdatum:
19. September 2016 (online)
![](https://www.thieme-connect.de/media/synlett/201620/lookinside/thumbnails/st-2016-u0485-l_10-1055_s-0036-1588601-1.jpg)
Abstract
Introduction of the Ns (o-nitrobenzenesulfonyl) group into 2-F3C-aziridine enhanced the useful electrophilic character of the ring, which in turn enabled a base-free ring-opening reaction with indoles under thermal conditions. This method constitutes a practical synthetic route to a variety of CF3-containing β-tryptamine derivatives, one of which could be transformed to the CF3-containing melatonin analogue in high overall yields.
Supporting Information
- Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0036-1588601.
- Supporting Information
-
References and Notes
- 1a Huang C-Y, Doyle AG. Chem. Rev. 2014; 114: 8153
-
1b Degennaro L, Trinchera P, Luisi R. Chem. Rev. 2014; 114: 7881
- 1c He Z, Zajdlik A, Yudin AK. Acc. Chem. Res. 2014; 47: 1029
- 1d Ha H.-J, Jung J.-H, Lee WK. Asian J. Org. Chem. 2014; 3: 1020
- 1e Florio S, Luisi R. Chem. Rev. 2010; 110: 5128
- 1f Singh GS, D’hooghe M, De Kimpe N. Chem. Rev. 2007; 107: 2080
- 1g Watson ID. G, Yu L, Yudin AK. Acc. Chem. Res. 2006; 39: 194
- 2a Dolfen J, De Kimpe N, D’hooghe M. Synlett 2016; 27: 1486
- 2b Dolfen J, Kenis S, Van Hecke K, De Kimpe N, D’hooghe M. Chem. Eur. J. 2014; 20: 10650
- 2c Waki M, Katagiri T, Matsuno K, Miyachi H. Tetrahedron Lett. 2014; 55: 6915
- 2d Moens M, De Kimpe N, D’hooghe M. J. Org. Chem. 2014; 79: 5558
- 2e Edman K, Ahlgren R, Bengtsson M, Bladh H, Bäckström S, Dahmén J, Henriksson K, Hillertz P, Hulikal V, Jerre A, Kinchin L, Káse C, Lepistö M, Mile I, Nilsson S, Smailagic A, Taylor J, Tjörnebo A, Wissler L, Hansson T. Bioorg. Med. Chem. Lett. 2014; 24: 2571
- 2f Kuzmich D, Bentzien J, Betageri R, DiSalvo D, Fadra-Khan T, Harcken C, Kukulka A, Nabozny G, Nelson R, Pack E, Souza D, Thomson D. Bioorg. Med. Chem. Lett. 2013; 23: 6640
- 2g Kenis S, D’hooghe M, Verniest G, Reybroeck M, Anh Dang Thi T, Pham The C, Thi Pham T, Törnroos KW, Van Tuyen N, De Kimpe N. Chem. Eur. J. 2013; 19: 5966
- 2h Rassukana YV, Bezgubenko LV, Onys’ko PP, Synytsya AD. J. Fluorine Chem. 2013; 148: 14
- 2i Yang Y, Huang Y, Qing F.-L. Tetrahedron Lett. 2013; 54: 3826
- 2j Kenis S, D’hooghe M, Verniest G, Duc Nguyen V, Anh Dang ThiT, Van Nguyen T, De Kimpe N. Org. Biomol. Chem. 2011; 9: 7217
- 3a Kurosato F, Ishikawa T, Yamada Y, Hanamoto T. Synlett 2015; 26: 1827
- 3b Kasai N, Maeda R, Furuno H, Hanamoto T. Synthesis 2012; 44: 3489
- 3c Maeda R, Ooyama K, Anno R, Shiosaki M, Azema T, Hanamoto T. Org. Lett. 2010; 12: 2548
- 4 Hirotaki K, Yamada Y, Hanamoto T. Asian J. Org. Chem. 2014; 3: 285
- 5a Michida M, Takayanagi Y, Imai M, Furuya Y, Kimura K, Kitawaki T, Tomori H, Kajino H. Org. Process Res. Dev. 2013; 17: 1430
- 5b Nakamura Y, Fujimoto T, Ogawa Y, Namiki H, Suzuki S, Asano M, Sugita C, Mochizuki A, Miyazaki S, Tamaki K, Nagai Y, Inoue S, Nagayama T, Kato M, Chiba K, Takasuna K, Nishi T. Bioorg. Med. Chem. 2013; 21: 3175
- 5c Nakamura Y, Fujimoto T, Ogawa Y, Sugita C, Miyazaki S, Tamaki K, Takahashi M, Matsui Y, Nagayama T, Manabe K, Mizuno M, Masubuchi N, Chiba K, Nishi T. ACS Med. Chem. Lett. 2013; 3: 754
- 5d Sugita C, Meguro M, Miyazaki S, Tamaki K, Takahashi M, Nagai Y, Nagayama T, Kato M, Suemune H, Nishi T. Bioorg. Med. Chem. Lett. 2012; 22: 4561
- 5e Nakamura Y, Ogawa Y, Suzuki C, Fujimoto T, Miyazaki S, Tamaki K, Nishi T, Suemune H. Heterocycles 2011; 83: 1587
- 5f Harrak Y, Barra CM, Delgado A, Castaño AR, Llebaria A. J. Am. Chem. Soc. 2011; 133: 12079
- 5g Harrak Y, Llebaria A, Delgado A. Eur. J. Org. Chem. 2008; 4647
- 5h Park W, Shin MH, Chung JH, Park J, Lah MS, Lim D. Tetrahedron Lett. 2006; 47: 8841
- 6a Kan T, Fukuyama T. Chem. Commun. 2004; 353
- 6b Miller SC, Scanlan TS. J. Am. Chem. Soc. 1998; 120: 2690
- 6c Miller SC, Scanlan TS. J. Am. Chem. Soc. 1997; 119: 2301
- 6d Fukuyama T, Jow C.-K. Tetrahedron Lett. 1995; 36: 6373
- 7 Szabó LF. J. Phys. Org. Chem. 2006; 19: 579
- 8 Experimental Procedure for 1 A 100 mL two-neck round-bottom flask equipped with a magnetic stir bar, a stopcock, and a three-way stopcock, was charged with 15 mL of hexane under argon. To this solution was added NaH (60% dispersion in mineral oil, 451.1 mg, 11.3 mmol, 1.2 equiv). After stirring for several minutes, the solvent was removed by syringe. To this flask was added 20 mL of THF. The flask was immersed in an ice bath. To this mixture was added NsNH2 (1.98 g, 9.79 mmol, 1.0 equiv) and stirred for 10 min at 0 °C. To this mixture was added β-(trifluoromethyl)vinyl diphenyl sulfonium triflate (4.42 g, 10.3 mmol, 1.05 equiv),3b and the resulting mixture was stirred at room temperature for 30 min. The reaction was carefully quenched with aq NH4Cl solution (20 mL) and extracted with EtOAc. The extraction was repeated twice. The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. The residue was initially purified by silica gel column chromatography (hexane–EtOAc = 30:1 then 2:1) to give yellow oil. Addition of hexane to this oily residue yielded a pale yellow precipitate, which was washed with Et2O to afford a white solid (2.64 g, 91%); mp 67.9–68.1 °C. IR (KBr): 3102, 1547, 1428, 1365, 1283, 1232, 1175, 987, 940, 852, 755 cm–1. 1H NMR (400 MHz, CDCl3): δ = 8.27 (d, J = 7.7 Hz, 1 H), 7.95–7.70 (m, 3 H), 3.70–3.50 (1 H), 3.09 (d, J = 6.9 Hz, 1 H), 2.90–2.65 (m, 1 H). 13C NMR (101 MHz, CDCl3): δ = 148.4, 135.4, 132.6, 131.5, 130.4, 124.6, 121.8 (q, J = 274.0 Hz), 37.4 (q, J = 42.1 Hz), 31.3. 19F NMR (376 MHz, CDCl3): δ = –73.2 (d, J = 2.7 Hz). GC-MS (EI, 70 eV): m/z = 186 (100) [Ns], 110 (15) [M+ – Ns], 92 (6), 76 (8), 64 (6), 60 (8), 50 (8). Anal. Calcd for C9H7F3N2O4S: C, 36.49; H, 2.38; N, 9.46. Found: C, 36.49; H, 2.27; N, 9.49.
- 9 Experimental Procedure for 3a (Table 1, Entry 6) To a round-bottom centrifuge tube with a screw cap was successively added aziridine 1 (60.1 mg, 0.203 mmol), indole 2a (34.4 mg, 0.294 mmol), and o-xylene (0.5 mL). The tube was immersed in a pre-heated oil bath (150 °C) and stirred at this temperature for 24 h. After cooling to room temperature, the mixture was directly purified by chromatography on a silica gel column (hexane–EtOAc = 20:1 then 1:1) to give 3a (70.4 mg, 84%) as a pale yellow solid; mp 192.0–193.0 °C. IR (KBr): 3412, 3340, 3119, 3095, 3072, 1541, 1426, 1343, 1272, 1185, 1125, 943, 855, 754 cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.66 (s, 1 H), 7.63 (d, J = 8.0 Hz, 1 H), 7.90–7.70 (m, 2 H), 7.30–7.05 (m, 5 H), 6.94 (s, 1 H), 5.80 (d, J = 8.3 Hz, 1 H), 4.50–4.75 (m, 1 H), 3.34 (d, J = 14.9 Hz, 1 H), 2.94 (dd, J = 14.9, 11.4 Hz, 1 H). 13C NMR (101 MHz, CDCl3–CD3OD = 4:1): δ = 145.7, 136.0, 133.1, 132.3, 132.0, 128.7, 126.0, 124.4 (q, J = 282.0 Hz), 124.3, 121.3, 119.0, 117.6, 111.5, 107.5, 107.0, 56.5 (q, J = 30.0 Hz), 24.1. 19F NMR (376 MHz, CDCl3): δ = –77.4 (d, J = 5.6 Hz). GC-MS (EI, m/z, 70 eV): 413 (8) [M+], 186 (2), 130 (100), 103 (4), 77 (3). Anal. Calcd for C17H14F3N3O4S: C, 49.39; H, 3.41; N, 10.17. Found: C, 49.11; H, 3.41; N, 10.06.
- 10 Experimental Procedure for 5b To a 25 mL two-neck round-bottom flask equipped with a magnetic stir bar, a stopcock, and a three-way stopcock, was successively added 3b (100.0 mg, 0.226 mmol), K2CO3 (62.6 mg, 0.453 mmol), thiophenol (46 μL, 0.390 mmol), and DMF (1.0 mL). The mixture was stirred at room temperature for 19 h. To the mixture was added a sat. aq NaCl (5 mL) and EtOAc (5 mL). After the organic layer was separated, an additional extraction with EtOAc was repeated two times. The combined organic solution was dried over Na2SO4, and concentrated in vacuo. The resulting oily residue was purified by chromatography on silica gel column (hexane–EtOAc–Et3N = 80:20:1 then 50:50:1) to give 5b (54.4 mg, 93%) as a white solid; mp 98.0–99.6 °C. IR (ATR): 3387, 3367, 3186, 2923, 1585, 1486, 1214, 1171, 1090, 1030, 897, 776 cm–1. 1H NMR (400 MHz, CDCl3): δ = 8.04 (s, 1 H), 8.05 (s, 1 H), 7.36 (d, J = 8.4 Hz, 1 H), 7.10 (s, 1 H), 7.02 (s, 1 H), 6.88 (d, J = 8.4 Hz, 1 H), 3.87 (s, 3 H), 3.65–3.50 (m, 1 H), 3.23 (d, J = 14.4 Hz, 1 H), 2.85–2.70 (m, 1 H), 1.38 (br s, 2 H). 13C NMR (101 MHz, CDCl3): δ = 154.2, 131.5, 1275, 126.6 (q, J = 282.3 Hz), 123.9, 112.5, 112.1, 110.2, 100.3, 55.9, 53.8 (q, J = 28.2 Hz), 26.0. 19F NMR (376 MHz, CDCl3): δ = –79.5 (d, J = 6.8 Hz). GC-MS (EI, 70 eV): m/z = 258 (22) [M+], 160 (100), 145 (17), 117 (10), 90 (3). Anal. Calcd for C12H13F3N2O: C, 55.81; H, 5.07; N, 10.85. Found: C, 55.91; H, 5.01; N, 10.75.
- 11 Experimental Procedure for 6b To a 25 mL two-neck round-bottom flask equipped with a magnetic stir bar, a stopcock ,and a three-way stopcock, was successively added 5b (45.3 mg, 0.175 mmol), Et3N (76 μL, 0.524 mmol), Ac2O (50 μL, 0.529 mmol), DMAP (4.2 mg, 20 mol%), and CH2Cl2 (1.0 mL). The mixture was stirred at room temperature for 3 h. To the mixture was added a sat. aq NaCl (5 mL). After the organic layer was separated, an additional extraction with EtOAc was repeated three times. The combined organic solution was dried over Na2CO4, and concentrated in vacuo. The resulting solid was recrystallized from acetone–pentane to give 6b (52.4 mg, 99%) as a white solid; mp 224.0–225.8 °C. IR (ATR): 3400, 3290, 1659, 1547, 1484, 1439, 1375, 1258, 1187, 1121, 1033 cm–1. 1H NMR (400 MHz, acetone-d 6–MeOH-d 4 = 2:3): δ = 7.76 (d, J = 8.6 Hz, 1 H), 7.11 (s, 2 H), 7.07 (s, 1 H), 7.23 (d, J = 8.6 Hz, 1 H), 4.95–4.80 (m, 1 H), 4.60–4.50 (m, 1 H), 3.82 (s, 3 H), 3.22 (d, J = 14.4 Hz, 1 H), 2.97 (dd, J = 14.4, 11.7 Hz, 1 H), 1.87 (s, 3 H). 13C NMR (101 MHz, acetone-d 6–MeOH-d 4 = 2:3): δ = 179.2, 155.2, 133.1, 128.9, 127.0 (q, J = 281.2 Hz), 125.0, 113.2, 112.9, 109.9, 101.0, 56.3, 52.3 (q, J = 29.6 Hz), 25.0, 22.6. 19F NMR (376 MHz, CDCl3–acetone-d 6–MeOH-d 4 = 15:2:3): δ = –76.6 (d, J = 6.8 Hz). GC-MS (EI, 70 eV): m/z = 413 (8) [M+], 186 (2), 130 (100), 103 (4), 77 (3). Anal. Calcd for C14H15F3N3O2: C, 56.00; H, 5.04; N, 9.33. Found: C, 55.72; H, 4.99; N, 9.13
For recent reviews, see:
For recent examples, see: